Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

NIR-to-visible upconversion nanoparticles for fluorescent labeling and targeted delivery of siRNA.

Jiang S, Zhang Y, Lim KM, Sim EK, Ye L.

Nanotechnology. 2009 Apr 15;20(15):155101. doi: 10.1088/0957-4484/20/15/155101. Epub 2009 Mar 24.

PMID:
19420539
2.

Upconversion nanoparticles in biological labeling, imaging, and therapy.

Wang F, Banerjee D, Liu Y, Chen X, Liu X.

Analyst. 2010 Aug;135(8):1839-54. doi: 10.1039/c0an00144a. Epub 2010 May 18. Review.

PMID:
20485777
3.

Upconversion: road to El Dorado of the fluorescence world.

Ong LC, Gnanasammandhan MK, Nagarajan S, Zhang Y.

Luminescence. 2010 Jul-Aug;25(4):290-3. doi: 10.1002/bio.1229. Review.

PMID:
20737581
4.

Small upconverting fluorescent nanoparticles for biomedical applications.

Chatterjee DK, Gnanasammandhan MK, Zhang Y.

Small. 2010 Dec 20;6(24):2781-95. doi: 10.1002/smll.201000418. Review.

PMID:
21064086
5.

Near-infrared upconversion nanoparticles for bio-applications.

Dou QQ, Guo HC, Ye E.

Mater Sci Eng C Mater Biol Appl. 2014 Dec;45:635-43. doi: 10.1016/j.msec.2014.03.056. Epub 2014 Apr 16. Review.

PMID:
25491873
6.

Targeted delivery of small interfering RNA: approaching effective cancer therapies.

Pirollo KF, Chang EH.

Cancer Res. 2008 Mar 1;68(5):1247-50. doi: 10.1158/0008-5472.CAN-07-5810. Review.

7.

Non-viral lipid-based nanoparticles for targeted cancer systemic gene silencing.

Moreira JN, Santos A, Moura V, Pedroso de Lima MC, Simões S.

J Nanosci Nanotechnol. 2008 May;8(5):2187-204. Review.

PMID:
18572631
8.

Recent advances in synthesis and surface modification of lanthanide-doped upconversion nanoparticles for biomedical applications.

Lin M, Zhao Y, Wang S, Liu M, Duan Z, Chen Y, Li F, Xu F, Lu T.

Biotechnol Adv. 2012 Nov-Dec;30(6):1551-61. doi: 10.1016/j.biotechadv.2012.04.009. Epub 2012 Apr 27. Review.

PMID:
22561011
9.

Cancer, chitosan nanoparticles and catalytic nucleic acids.

Tan ML, Choong PF, Dass CR.

J Pharm Pharmacol. 2009 Jan;61(1):3-12. doi: 10.1211/jpp/61.01.0002. Review.

PMID:
19126291
10.

Progress in siRNA delivery using multifunctional nanoparticles.

Gao W, Xiao Z, Radovic-Moreno A, Shi J, Langer R, Farokhzad OC.

Methods Mol Biol. 2010;629:53-67. doi: 10.1007/978-1-60761-657-3_4. Review.

PMID:
20387142
11.

Phosphorothioate-stimulated cellular uptake of siRNA: a cell culture model for mechanistic studies.

Detzer A, Overhoff M, Mescalchin A, Rompf M, Sczakiel G.

Curr Pharm Des. 2008;14(34):3666-73. Review.

PMID:
19075742
12.

Delivery of RNA interference therapeutics using polycation-based nanoparticles.

Howard KA.

Adv Drug Deliv Rev. 2009 Jul 25;61(9):710-20. doi: 10.1016/j.addr.2009.04.001. Epub 2009 Apr 5. Review.

PMID:
19356738
13.

Folate-targeted therapeutic and imaging agents for cancer.

Low PS, Kularatne SA.

Curr Opin Chem Biol. 2009 Jun;13(3):256-62. doi: 10.1016/j.cbpa.2009.03.022. Epub 2009 May 4. Review.

PMID:
19419901
14.

Nanoparticles in cellular drug delivery.

Faraji AH, Wipf P.

Bioorg Med Chem. 2009 Apr 15;17(8):2950-62. doi: 10.1016/j.bmc.2009.02.043. Epub 2009 Feb 26. Review.

PMID:
19299149

Supplemental Content

Support Center